Skip to main content

Richard Myers, Peter DeComo, John Kuzmishin, John Miclot, Elizabeth Woo, Joseph Keegan, Winnie Wan

Premium
Richard Myers, chair of genetics at the Stanford University School of Medicine and director of the Stanford Human Genome Center, will be leaving Stanford next year to serve as scientific director of the HudsonAlpha Institute for Biotechnology in Huntsville, Ala., Alabama Governor Bob Riley said last week.
 
Myers, an Alabama native, will move slowly from a consulting role at HAI over the coming year before he takes on the full-time position next fall. Meantime, he will continue his work running the Stanford HGC and as a professor at the university.
 

 
The Pittsburgh Life Sciences Greenhouse has elected several new members to its board of directors, the organization announced last week.
 
Electees include Peter DeComo, chairman and CEO of Renal Solutions; John Kuzmishin, VP of strategic business initiatives at the University of Pittsburgh Medical Center; John Miclot, president and CEO of Respironics; and Elizabeth Woo, VP of biotechnology for Thermo Fisher Scientific.
 

 
ForteBio announced this week that Joseph Keegan has been named president and chief executive officer, beginning September 24, 2007. ForteBio founding CEO Winnie Wan will continue to serve on the board of directors.
 
Keegan was most recently president and chief executive officer of Molecular Devices before it was acquired by MDS earlier this year.
 
Prior to joining Molecular Devices, Keegan served as president of worldwide tissue culture and vice president, general manager of worldwide flow cytometry at Becton Dickinson. Prior to his tenure at Becton Dickinson, Keegan was vice president of the microscopy and scientific instruments division of Leica.
 

He currently serves on the board of directors of Alpha Innotech, BioImagene, and Seahorse Bioscience.

The Scan

Possibly as Transmissible

Officials in the UK say the B.1.617.2 variant of SARS-CoV-2 may be as transmitted as easily as the B.1.1.7 variant that was identified in the UK, New Scientist reports.

Gene Therapy for SCID 'Encouraging'

The Associated Press reports that a gene therapy appears to be effective in treating severe combined immunodeficiency syndrome.

To Watch the Variants

Scientists told US lawmakers that SARS-CoV-2 variants need to be better monitored, the New York Times reports.

Nature Papers Present Nautilus Genome, Tool to Analyze Single-Cell Data, More

In Nature this week: nautilus genome gives peek into its evolution, computational tool to analyze single-cell ATAC-seq data, and more.